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Abstract 
We investigated the effect of cyclosporin (CsA) on HIV-gpl20-dependent induction of cell death by apoptosis of human T cell clones specific for 
influenza virus haemagglutinin and restricted by HLA-DRl. Preincubation of the clones with gpl20 induced a large inhibition of their proliferation 
which was paralleled by the induction of apoptosis. Exposure to the specific antigen alone was able to trigger apoptosis in a significant fraction of 
cells, this effect was potentiated by pretreatment with gpl20. Apoptosis was characterized by the typical morphological changes and by the expression 
of ‘tissue’ Transglutaminase (tTG), one of the few characterized effector elements of programmed cell death. Interestingly, the tTG protein induction 
was detectable within the first 24 hours following the gpl20 treatment and preceded the appearance of the typical apoptotic phenotype. Noteworthy, 
CsA treatment prevented the gpl20-dependent induction of apoptosls by blocking the activation of the Ca”-dependent effector elements uch as 
tTG. 
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1. Introduction 
The cellular and molecular mechanisms at the basis of 
the dramatic immune cell loss caused by HIV in patients 
suffering acquired immunodeficent syndrome (AIDS) 
are not yet established [ 1.21. One of the unresolved ques- 
tion about the pathology of HIV infection concerns the 
functional disappearence of T cells specific for ‘recall’ 
microbial antigen at early stages of the disease [I]. This 
suggests that some indirect mechanism, other than virus- 
induced cytopathogenicity, may also be operative [3]. It 
has been reported recently that lymphocytes from sero- 
positive individuals (stage II), and from ARC and AIDS 
patients undergo programmed cell death or apoptosis 
when cultured in vitro in the absence of growth factors 
or when stimulated with bacterial superantigen [4-91. 
Apoptosis is the silent (not associated with inflamma- 
tion) physiological process of cell death leading to the 
controlled elimination of single cells from tissues [lo-l 21. 
Independent from their origin, cells undergoing apopto- 
sis display common morphological features, thus sug- 
gesting the existence of a general gene-regulated pathway 
*Corresponclmg author. Fax: (39) (6) 202 3500. 
of physiological death [l&12]. The Ca2’-dependent en- 
zymes ‘tissue’ transglutaminase (tTG) and endonuclease 
are among the genes recently identified as effector ele- 
ments of the apoptotic cell death program [lO-121. The 
activation of tTG in apoptotic cells leads to the forma- 
tion of highly cross-linked intracellular protein polymers 
which play a fundamental role in the induction of the 
irreversible structural changes featuring cells dying by 
apoptosis [13,14]. 
Apoptosis plays a key role in the homeostasis of the 
immune system, not only is it involved in the elimination 
of self-recognizing T lymphocytes in the thymus [ 15,161, 
but this death mechanism also seems to be activated in 
mature T cells by the separate ligation of CD4 and the 
T cell receptor for antigen [171. It has been suggested that 
AIDS can be considered an activation-induced isease 
and immunosuppressors such as CsA, which prevent ac- 
tivation, has already been introduced in its therapy [IS]. 
In an attempt to get further insight into the molecular 
mechanisms involved in the onset of apoptosis in T-cells 
we investigated the role of HIV gp120 and CsA at the 
clonal level. To this aim, well characterized influenza- 
specific CD4’ T cell clones have been analysed for their 
proliferative response and for apoptosis induction in dif- 
ferent culture conditions in the presence of gp120 and/or 
CsA. 
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2. Materials and methods 
2.1. Influenza virus antigen and HIV gp120 preparation 
The antigen used in this study was the synthetic peptide 306324 
derived from haemoagglutinin (HA). The peptide was prepared by solid 
phase synthesis using standard t-Boc chemistry in ‘T bags’ using com- 
mercially available amino acids (Novabiochem, Laufelfingen). The pep- 
tide was cleaved from the resin by treatment with hydrogen fluoride. 
Purity was determined by high pressure liquid chromatography and 
amino acid analysis. 
HIV-l recombinant gp120 produced in the bacolavirus ystem was 
purchased from American 3iot~hnolo~ (USA). 
2 2. Antibodies 
The anti-gpl20 polyclonal rabbit antibodies were purchased from 
American F?&technology (USA); the mouse anti-human CD4 mAb 
0KT4 from Ortho (USAk the mouse anti-human CD3 mAb OKT3 
from Ortho (USA); the affinity-purified monospecific rabbit IgG raised 
against soluble ‘tissue transglutaminase’ of human red blood cells was 
a kind gift from L. Fesus (Department of Biochemistry, University 
Medical School of Debrecen, Debrecen, Hungary). Rabbit antiserum 
specific for cow glial fibrillary acidic protein were obtained from Da- 
kopatts (Hagersten). 
2.3. Cell lines 
The DRl-expressing murine L-cells (0.5-3.1) [19] were maintained in 
culture in DMEM supplemented with 10% FCS in 25 cm* tissue culture 
flasks and subcultured, after trypsin treatment, at 1:lO dilution twice 
weekly. 
EBV-transformed l~phoblastoid B-cell lines (B-LCLs), from the 
10th International Histocompatibility Workshop, were cultured in 
RPM1 1640 medium supplemented with 10% FCS, 2 mM r_-glutamine, 
penicillin at 50 units/ml, and streptomycin at 50 &ml in 25 cm’ flasks 
and were regularly passaged. 
2 4. T cell clones 
T cell clones HC4 and HC6 were generated from a DR1,4 individual 
by stimulating PBMC with punfied influenza HA (S,@ml), and cloned 
by limited dilution in Terasaki plates at 1 cell/well with lo4 irradiated 
autologous PBMC, 1 &ml HA306324 peptide and 20 U/ml recombi- 
nant IL-2 (rIL-2) (Boeringher Mannheim, Germany). The clones were 
maintained in culture by weekly stimulation with autologous PBMC, 
HA306324 peptide and rIL-2 [16]. 
2.5. gpl20 and CsA treatment 
T cell clones were plated out in 24-well plates (3-5 x lo5 cells/well) 
m the presence of gp120 and rIL-2 (20 Ulml), in a total volume of 500 
~1. After 24-48 h incubation, the cells were harvested, washed and left 
to ‘rest’ for a further 2448 h in the absence of IL-2. T cells were 
analyzed at both times for their proliferation as well as apoptosis. In 
some experiments, T cell clones were also cultured with HA306324 
peptide- pulsed DRl-expressing L cells during the last 24 h in the 
presence or in the absence of various concentration of CsA (Sandoz, 
Switzerland; as indicated in the figure legends). 
2.6. T ceil proliferation assay 
T cell clones (lo4 cells/well) were cultured in the presence of Mitomy- 
tin-C (65 &ml) (Sigma, St. Louis, MO) treated B-LCL’s or DRI- 
expressing L cells transf~tants (2 x lo4 cells/well) in flat-bottom 
microtiter plates, in a total volume of 200 ~1. For antigen-specific 
responses, the antigen presenting cells were pre-pulsed with antigen. 
Wells were pulsed with 1 ,&i of tritiated thymidine ([3H]TdR) (Amer- 
sham International, UK) after 48 h and the cultures harvested onto 
glass fiber filters 18 h later. Proliferation was measured as [‘H]TdR 
incorporation by liquid scintillation spectroscopy (Optifluor was from 
Packard, Zurich). The results are expressed as mean cpm for triplicate 
cultures. Standard errors were routinely less than 10%. 
2.7. Immunocytochemistry 
Immunocytochemical staining of human T cells was performed using 
as primary antibody an affinity-purified monospecific IgG raised in 
rabbits against human red blood cell soluble tTG (1: 100) [123. Incuba- 
tions with the primary antibody were carried out in a wet chamber 
overnight at 4°C. A biotinylat~ goat anti-rabbit IgG, as second anti- 
body, was used followed by a preformed avidin-horseradish peroxidase 
complex (Immunon, MI, USA). The reaction was developed using 
aminoethylcarbazole (AEC), (CRL, USA) as chromogen substrate and 
0.01% H,O,. Cells were counterstained in Mayer’s haemalum. En- 
dogenous peroxidase activity was blocked by methanol-H:O, 
2.8. Evaluation of the apoptotic index 
The percentage of apoptotic cells was evaluated by counting the tTG 
positive cells showing the typical apoptotic morphology (shrunken cells 
with condensed chromatin; Fig. 3D, arrows) as well as the apoptotic 
ghosts (Fig. 3E,F, arrow heads} scored at the light microscopy {La- 
borlux D; Leitz, Wetzlar, Gerry) over 1.000 total cells (including the 
apoptotic ones). In order to avoid subjective bias, the counts were 
carried out by two different workers and the results pooled. 
3. Results 
The human T cell clones HC4, and HC6 restricted by 
HLA-DRl and raised against influenza heamagglutinin 
(specific for the HA peptide (306-324); [19]) were cul- 
tured for 48 h with gp120 and IL-2, followed by 48 h in 
tissue culture medium (without any further addition of 
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Fig. 1. Functional inhibition induced by gpl20 on T cell clones specific 
for HA306324 antigen. The human T cell clones HC4 and HC6 were 
exposed to gp120 (lOpg/ml) in the presence of 20 U/ml of rIL-2 for 48 
h. After two extensive washes, the T cells were left to rest for a further 
48 h and then their proliferative capacity to antigen pulsed DRl-ex- 
pressing B-LCL was tested. Symbols: fo) rIL-2 (20 U/ml); (m) rIL- 
2 + gpl20 (10 &ml). The results are expressed as mean cpm for tripli- 
cate cultures. Standard errors were routinely less than 10%. The results 
represent a typical experiment out of 5. 
Antigen mmcentration lO@gftnl 
Fig. 2. Competitive e&ct of an antj-~l~O antibody on the ~~~~i~~~ 
oFpr~l~~erati~e response of human T ceft done WC4. The cell clone HC4 
was treated either with gpl2Q (10 puglml) for 48 h or with the gpl2O 
pretreated with its specific antibody. As control, an unrelated antiserum 
was used. After two extensive washes, the HC4 proliferative capacity 
was tested against DRI-expressing B-LCL pulsed with HAI%-324 
peptide. The results are the mean of triplicate measurements in two 
different experiments. The results are expressed as mean cpm for tripl- 
icate cultures. Standard errors were less than IW%. 
IL-21, The T cells were then harvested, washed and trans- 
ferred to a proliferation assay in the presence of DRI- 
expressing B-LCL-pulsed with different concentrations 
of HA306324 peptide. Fig. 1 shows that pre-incubation 
with 10 ,&ml of gp120 induces a reduction of subse- 
quent proliferation between 30-70%, depending on the 
clone used. The effect of gpf20 on the prol~feratjve re- 
sponse of the T cell clone to DRl-expressing L cells 
pulsed with HA30&-324 peptide (1 ~&ml) was dose-de- 
pendent (data not shown) and its speciality was demon- 
strated by protecting from inhibition by gp120 preincu- 
bation with an anti-gpl20 antiserum before addition to 
T ceil clones (Fig. 2). CsA treatment (at 200 n~rnl~ com- 
pletely abolished the residual proliferative capacity 
shown by both HC4 and HC6 clones after gp120 treat- 
ment (data not shown). FACS analysis on the HC4 clone 
showed that 24 h of gpl20 treatment induced a marked 
decrease of CD4 expression which was reversed during 
an additional 48 h culture in fresh medium in the pres- 
ence of K-2; no modulation of CR3 expression was 
caused by gp120 under the same culture conditions de- 
scribed (data not shown), 
To analyse whether the interaction between the HIV 
protein gp120 and the CD4 receptor can cause apoptosis 
in ~~infe~t~d T cells, we have ~nvesti~ated~ beside mor- 
phology, the tTG protein expression by immunocyto- 
chemistry using an affinity-purified rabbit antibody 
raised against human red blood cell tTG which does not 
cross-react with other TGs as previousIy described 
[12,13,20]. Fig. 3 shows that tTG protein is induced in 
the clone HC4 during the first 24 h exposure to gp120 
(Fig. 3C). In fact, the tTG protein is not detectable in 
untreated cells (Fig. 3B) while the number of tTG-posi- 
tive cells reached a value close to 30% following 24 h 
treatment with gpl20 (Fig. 3C). The tTG protein level 
was further increased after exposure for additional 24 h 
to the specific antigen and, at his time, its expression was 
revealed in T-cells characterized by typical apoptotic 
phenotype (shrunken cell containing condensed chroma- 
tin; Fig. 3D). In culture, apoptotic cells undergo second- 
ary necrosis [l&12]. This event is highlighted in cultures 
incubated with gpi20 for 48 h by less defined positivity 
with the tTG antibody and loss of intracellular organ- 
elles (Fig. 3E.F). The remaining cell ghosts (Fig. 3E,F) 
are identical to the highly resistant cross-linked scaffold 
assembled through the action of tTG in apoptotic cells 
(Fig_ 3A), By counting the tTG positive cells showing the 
apoptotic morphology in addition to the cross-linked 
apoptotic remnants we could quantify the apoptotic 
index in our cultures. Data indicate that the inhibition 
of proliferation observed after exposure to gp120 (Fig, 
1) was paralleled by the induction of apoptosis in both 
clones, in the presence or absence of HA306324-pulsed 
DRl-expressing L cells (Fig. 4). Altho~~i~” some differ- 
ences were observed between the clones, apoptosis was 
induced in 5060% of cells after gp120 pretreatment and 
subsequent exposure to HA3~~324-pulsed DR 1 -ex- 
pressing L cells (Fig.. 4). ~ote~ortby~ exposure to 
~A306-3~4-pulsed DRl-expressing L cells triggered ap- 
optosis per se in a significant proportion of T cells (Fig. 
4). The specificity of the effect exerted by the gp120 was 
demonstrated by protecting from the induction of apop- 
to&s in T cell clones by gp120 prein~ubation with an 
anti-gpl20 antiserum. In fact, the data reported in Fig. 
5 clearly indicate that preineubation of gp120 with anti- 
gp120 antibody prevented the inhibition of the prolifera- 
tive capacity (Fig. 1) by blocking apoptosis, In Fig. 6 the 
effect of CsA on T-cells apoptosis induced by gp120 
followed by exposure to the specific antigen is shown 
Data clearly indicate that CsA completely prevents the 
induction of apoptosis subsequent o the exposure to 
gp 120 and HA306-324-pulsed DR 1 -expressing L cells 
(Fig. 6A). However, the block of apoptosis is not associ- 
ated to the down-re~latio~ of the specific: effector ele- 
ments expressed in the late stages of the apoptotic path- 
way. In fact, CsA treatment leads to the accumulation 
of an increa.sed number of cells expressing the tTG pro- 
tein (Fig. 6Bf. 
Previous reports have indicated that T cells, either 
polyclonal or monoclonal, after preincubation with 
gpl20 in vitro, become refractory to the stimulation 
through the T cell receptor [21]. Several mechanisms 
could acconnf for gp~2O”ind~~ed nhibitjon. It is possible 
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Fig. 3. ‘Tissue’ transglutaminase expression in gpl20 treated human T cells. T cells (&one HC4) were smeared on slides, fixed in 2.5% parafor- 
maldehyde and, after immunostaini~~ with the monospecific anti-tTG antibody, counterstained with Mayer’s haemaium, as described in section 2. 
Panel A shows the morphological features of highly cross-linked apoptotic bodies isolated from human T cell clone HC4 upon preincubation with 
gp120 and exposition to the HA306-324-pulsed DRl-expressing 1 cells as previously described [I91 (phase contrast; bar = 10 ,um). Panel B shows 
the untreated T cells grown in presence of rIL-2; note the absence of positive reaction to the tTG antibody (bar = 12 pm). Panel C shows the clone 
HC4 pretreated with gp 120 for 24 h; about 30% of the T cells present an intense tTG expression in the cytoplasm (arrow heads; bar = 12 JUII). Panels 
D-F show the clone HC4 pretreated with gpt20 for 24 hand then exposed for other 24 (C) or 48- (D-F) h to #he HA3OfS-324 pulsed DRl-expressing 
1 &Is. In these pands, the T ceils were heavily stained with the anti-tTg antibody and showed the typical apoptotic morphology (shrunken cytoplasm 
and marginated condensed chromatin; D, arrows; bar = 10 pm). After 48 h in the presence of HA306-324-pulsed DRl-expressing L cells (E-F), 
apoptotic cells underwent secondary necrosis progressively losing their organelles (note the absence of the nuclear staining E-F, arrows heads) 
includmg positivity to the tTG antibody (E, arrow; bar = 3 pm), thus indicating different stages of degradation i  the absence of phagocytosis (E-F, 
arrow heads; E bar = 8 gm). 
that occupancy of the CD4 molecuIe with gp120 could [22]* Alternatively, in models dealing with T cell stimu’fa- 
reduce availability of CD4 for interaction with MHC tian by cross-linked monoclonal antibodies specific for 
class II molecules on the APC (antigen presenting cells) CD3 or TCR in APC-free systems, the gpl20-dependent 
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Fig. 4. Apoptosis induced by gp120 m T cell clones pecific for HA306 
324 peptide. The human T cell clones HC4 and HC6 were exposed to 
either riL-2 (20 U/ml) alone or rIL-2 and gpl20 (IO gglml) for 48 h. 
After two extensive washes, T cells were cultured in the presence 
(hatched bars) or absence (open bars) of HA306-324 peptrde-pulsed 
DRI-expressing L cells for 48 h. Apoptosis was quantified as described 
in section 2. Results represent he mean + SD. of five different exper- 
iments. 
suppression of T cell proliferation can be mainly ascribed 
to the inhibition of the CD3/TCR phospholipase C 
transduction pathway [23]. In the majority of the studies 
dealing with the inhibition of T cell proliferation by 
gp120, the final effect of gp12OCD4 interaction is de- 
scribed as functional deletion, anergy, or temporary sup- 
pression [21,23]. In fact, the proliferative response to 
IL-2 is conserved, and removal of gp120 in the presence 
of IL-2 could reverse the inhibition [24]. 
The results presented here support a third possible 
mechanism of gpl20-induced T cell inhibition, namely 
the induction of apoptosis. It has been recently reported 
that when preceded by ligation of CD4, signalling 
through TCR results in T cell unresponsiveness which 
elicits cell death of mature T cells by apoptosis [7,15]. 
The interest in such a phenomenon is enhanced by recent 
reports showing that T cells from AIDS patients are 
‘primed’ for apoptosis [.5,7] and that clonal deletion of 
particular TCR VP regions is present in AIDS patients 
[24]. Against this background, we addressed the possibil- 
ity that incubation with gp120 causes apoptosis in CD4’ 
T cells either before or after stimulation through TCR 
occupancy. In particular: (a) presentation of the specific 
antigen itself induces apoptosis in the T cell clones; (b) 
gp120 induces apoptosis which is further enhanced by 
stimulation with the antigen; (c) CsA prevents the anti- 
gen-dependent induced T-cell apoptosis, 
The induction of apoptosis in the T-cells was charac- 
terized by the appearance of the morphofogi~lly typical 
apoptotic phenotype (condensed cells with pycknotic 
chromatin; Fig. 3D) DNA fragmentation (data not 
shown) and by the expression of one of the few charac- 
terized effector elements of the apoptotic pathway, tTG 
[12,26-281. It is interesting to note that untreated cells do 
not express the tTG protein, while the enzyme is mark- 
edly induced upon the binding of gp120 to the CD4 
receptor and/or after stimulation with the antigen (Figs. 
3C and 6B). This tTG protein expression in the absence 
of the extreme apoptotic phenotype could highlight a 
pre-apoptotic stage during which the T cells are ‘primed’ 
for apoptosis which is then affected if the primed cell 
receives additional CD3-transduced signals. According 
to the current knowledge [IO-121, only a sustained in- 
crease in the intracellular Ca2+ level triggers the irrevers- 
ible commitment o death by activating the effector genes 
(tTG, endonuclease) which in turn modify the structure 
of the cells toward the typical morphology of apoptosis 
1121. In fact, tTG is a Ca2’ dependent enzyme that is not 
active at the Ca’+ levels no~ally detected in viable cells 
(121. However, the raise in the intracellular Ca2” concen- 
tration reported in cells undergoing apoptosis is suffi- 
cient to activate the enzyme [19,2628]. In keeping with 
these findings is important to mention that CsA is an 
immunosuppressive agent that blocks T-cells activation 
by preventing lymphokine production and by interfering 
with the TCR-mediated Ca2’ signal transduction [30]. 
On such a basis it very likely that CsA, by preventing the 
increase of intracellular free Ca’+, inhibits the activation 
of the effector ‘killer’ elements which elicit the irreversi- 
ble final events of the apoptotic pathway. In line with this 
hypothesis is the acc~ulation, in the presence of a re- 
duced apoptosis, of ‘primed’ tTG positive cells upon 
CsA treatment (Fig. 6B). 
The mechanism through which gp12OCD4 interac- 
tion primes cell for apoptosis is not clear. Steric pertur- 
bation of CD4-TCR interaction may be responsible for 
the T cell anergy induction [21]. Inappropriated kinase 
activity could also be involved [21]. As in immature thy- 
mocytes [1 S,3 11, mature murine T cells [ 171 and hybrido- 
mas [ 171, the induction of apoptosis is not an obligatory 
response to TCR stimulation, but is the consequence of 
incomplete signal transduction 1291. This suggestion is 
consistent with the observation that gp120 can stimulate 
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I:lg. 5. Competitive effect of an anti-gpl20 antibody on the induction of apoptosis of human T cell clone HC4. The T cell clone HC4 was treated 
either with gp120 (10 j@rnl) for 48 h (3-4) or with the gp120 pretreated with its specific antibody (34,@ml) (5-6). Pretreated T cells were exposed 
for additional 48 h to HA306324 peptide-pulsed DRl-expressing L cells (2-3,6). The results are the mean of duplicate measurements carried out 
in two different expe~ments and are expressed as% of apoptosis (see section 2). 
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IL-2 receptor expression [32] and IFN production [33], 
but it does not appear to increase tyrosine protein kinase 
signalling 1341. 
Although the cytopathic effect of HIV has been shown 
to be associated with apoptosis [4-9,35,36] and the inhi- 
bition of cell proliferation of T cells from AIDS patients 
due to an active T cell death process, no biochemical 
events associated to this ‘primed stage’ induced by gp120 
[4-7,35,36] has been reported. We show here that the 
binding of gp120 to the CD4 molecules is able to induce 
the expression and the subsequent activation of effector 
elements of cell death program such as tTG. 
In conclusion, we show here CD4+ T cells from estab- 
lished T cell clones undergo apoptosis after either expo- 
sure to gp120 and/or stimulation with nominal antigen. 
Furthermore, the finding that CsA seems to prevent the 
gp120 induced apoptosis by blocking the activation of 
the enzyme/s catalyzing the final irreversible vents of the 
apoptotic pathway its worthnoting in view of the use of 
specific immunosuppressive drugs in AIDS therapy. 
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Fig. 6. Effect of CsA on (A) gp120 and/or antigen presentation induced 
apoptosis of human T cell clone HC4, and on (B) tTG expression. The 
human T cell clone HC4 was exposed to gpl20 (10 &ml) in the 
presence of 20 U/ml of rIL-2 for 24 h. After two extensive washes, cells 
were exposed to DR 1 -expressing B-LCL pulsed with HA306-324 pep- 
tide in the presence and absence of different concentrations of CsA. (A) 
The results arc the mean of duplicate measurements in two different 
experiments and are expressed as% of apoptosis (see section 2); (B) the 
results are the mean of triplicate measurements in two different exper- 
iments and are expressed as % of tTG positive cells (see section 2). 
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